Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness.

Autor: Shirali AS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hu MI; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chiang YJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Graham PH; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sosa JA; Department of Surgery, University of California-San Francisco (UCSF), San Francisco, CA 94143, USA., Perrier N; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Brown S; Department of Endocrinology, Houston Methodist Hospital, Houston, TX 77030, USA., Holla VR; Institute of Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dadu R; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Busaidy N; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sherman SI; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cabanillas M; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Waguespack SG; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Grubbs EG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Journal of the Endocrine Society [J Endocr Soc] 2024 Apr 24; Vol. 8 (6), pp. bvae048. Date of Electronic Publication: 2024 Apr 24 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.

Autor: Bilezikian JP; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Khan AA; Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada., Silverberg SJ; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Fuleihan GE; Calcium Metabolism and Osteoporosis Program, WHO CC for Metabolic Bone Disorders, Division of Endocrinology, American University of Beirut, Beirut, Lebanon., Marcocci C; Department of Clinical and Experimental Medicine, University of Pisa, Endocrine Unit 2, University Hospital of Pisa, Pisa, Italy., Minisola S; Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, 'Sapienza', Rome University, Rome, Italy., Perrier N; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sitges-Serra A; Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain., Thakker RV; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford, UK., Guyatt G; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada., Mannstadt M; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Potts JT; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Clarke BL; Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA., Brandi ML; Fondazione Italiana sulla Ricerca sulle Malattie dell'Osso (F.I.R.M.O. Foundation), Florence, Italy.

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Nov; Vol. 37 (11), pp. 2293-2314. Date of Electronic Publication: 2022 Oct 17.

TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.

Autor: Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ma J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Roman Gonzalez A; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Endocrinology, San Vicente Fundación-Universidad de Antioquia, Medellin, Colombia., Varghese J; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Perrier N; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Habra MA; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Graham P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Waguespack SG; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Apr 13; Vol. 108 (5), pp. 1132-1142.

Surgical Aspects of Primary Hyperparathyroidism.

Autor: Perrier N; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas M D Anderson Cancer Center, Houston, TX, USA., Lang BH; Department of Surgery, Queen Mary Hospital, Pokfulam, Hong Kong., Farias LCB; Division of Endocrinology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil., Poch LL; Endocrine Surgery Unit, Universitat Autònoma de Barcelona, Barcelona, Spain., Sywak M; Endocrine Surgery Unit, University of Sydney, Sydney, Australia., Almquist M; Department of Surgery, Skåne University Hospital, Lund University, Lund, Sweden., Vriens MR; Department of Surgical Oncology and Endocrine Surgery, University Medical Center, Utrecht, The Netherlands., Yeh MW; Department of Surgery, Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA., Shariq O; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Headington, UK., Duh QY; Department of Surgery, University of California, San Francisco, CA, USA., Yeh R; Memorial Sloan Kettering Cancer Center, Molecular Imaging and Therapy Service, New York, NY, USA., Vu T; Neuroradiology Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA., LiVolsi V; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sitges-Serra A; Endocrine Surgery Unit, Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Nov; Vol. 37 (11), pp. 2373-2390. Date of Electronic Publication: 2022 Oct 17.